AI assistant
Pulmonx Corp — Director's Dealing 2021
Jun 12, 2021
34428_dirs_2021-06-11_1c33d6f9-0e02-49fd-b444-1261c270dfef.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Pulmonx Corp (LUNG)
CIK: 0001127537
Period of Report: 2021-06-01
Reporting Person: Mead Dana G Jr. (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-06-01 | Common Stock | A | 2810 | $0.00 | Acquired | 29125 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 4076 | Indirect |
Footnotes
F1: Represents grant of Restricted Stock Units payable solely in common stock of the Issuer that will vest on the one-year anniversary of the date of grant of June 1, 2021.
F2: The shares received as a liquidation distribution from KPCB XIII Associates, LLC, the managing member of Kleiner Perkins Caufield & Byers XIII, LLC, the direct holder of the shares as disclosed in prior reports.
F3: The shares are held directly by the Dana G. Mead, Jr. And D'Arcy Gage Mead, or Their Successors, as Trustees of The Mead Family Trust Created Uta Dated August 4, 1998, as Amended.